Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION (Tables)

v3.8.0.1
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Dec. 31, 2017
SHARE-BASED COMPENSATION  
Summary of the share options activities

 

 

 

 

 

Weighted

 

Weighted

 

Aggregate

 

 

 

 

 

average

 

remaining

 

intrinsic

 

 

 

Number of

 

exercise

 

contractual

 

value

 

 

 

shares

 

USD

 

years

 

USD

 

Outstanding as of March 31, 2015

 

3,885,667

 

2.66

 

 

 

 

 

Granted

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

Expired

 

(1,981,600

)

2.72

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of March 31, 2016

 

1,904,067

 

2.61

 

 

 

 

 

Granted

 

900,000

 

1.71

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

Forfeited

 

(100,000

)

1.71

 

 

 

 

 

Expired

 

(253,000

)

3.60

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of March 31, 2017

 

2,451,067

 

2.21

 

 

 

 

 

Granted

 

50,000

 

2.35

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

Forfeited

 

(50,000

)

1.71

 

 

 

 

 

Expired

 

(74,000

)

3.60

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2017

 

2,377,067

 

2.18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest as of December 31, 2017

 

2,377,067

 

2.18

 

7.46

 

556,612

 

 

 

 

 

 

 

 

 

 

 

Exercisable as of December 31, 2017

 

842,337

 

2.54

 

6.23

 

51,431

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of information relating to options outstanding and exercisable

 

Options outstanding as of December 31, 2017

 

Options exercisable as of December 31, 2017

 

 

 

Exercise

 

Remaining

 

 

 

Exercise

 

Remaining

 

Number of

 

Price

 

Contractual

 

Number

 

Price

 

Contractual

 

Shares

 

per Share

 

Life

 

of Shares

 

per Share

 

Life

 

 

 

USD

 

Years

 

 

 

USD

 

Years

 

100,000

 

4.75

 

0.07

 

100,000

 

4.75

 

0.07

 

7,607

 

2.69

 

1.16

 

7,607

 

2.69

 

1.16

 

1,469,460

 

2.24

 

7.12

 

734,730

 

2.24

 

7.12

 

750,000

 

1.71

 

9.05

 

 

 

 

50,000

 

2.35

 

9.61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,377,067

 

2.18

 

7.46

 

842,337

 

2.54

 

6.23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Summary of assumptions used in the valuation model

 

 

 

Twelve months ended
March 31,

 

Nine months ended
December 31,

 

 

 

2016

 

2017

 

2017

 

 

 

 

 

 

 

 

 

Expected dividend yield

 

0%

 

0%

 

8.7%

 

Expected volatility

 

50%

 

63%

 

60%

 

Expected term

 

0.25

 

6.08

 

6.08

 

Risk-free interest rate (per annum)

 

0.72%

 

1.98%

 

1.96%

 

 

Non-vested shares  
SHARE-BASED COMPENSATION  
Summary of the non-vested shares activities

 

 

 

 

 

Weighted
average

 

 

 

Number

 

grant date

 

 

 

of shares

 

fair value

 

 

 

 

 

USD

 

Outstanding at March 31, 2015

 

445,000

 

3.819

 

Granted

 

 

 

Vested

 

(325,000

)

4.437

 

Forfeited

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2016

 

120,000

 

2.145

 

 

 

 

 

 

 

Granted

 

2,700,000

 

1.650

 

Vested

 

(60,000

)

2.145

 

Forfeited

 

(60,000

)

1.650

 

 

 

 

 

 

 

Outstanding at March 31, 2017

 

2,700,000

 

1.661

 

 

 

 

 

 

 

Granted

 

 

 

Vested

 

(60,000

)

2.145

 

Forfeited

 

(15,000

)

1.650

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

2,625,000

 

1.650

 

 

 

 

 

 

 

 

Schedule of allocation of recognized compensation expense for non-vested shares

 

 

 

Twelve months ended
March 31,

 

Nine months ended
December 31,

 

 

 

2016

 

2017

 

2017

 

 

 

RMB

 

RMB

 

RMB

 

Cost of revenues

 

90,002

 

455,115

 

1,791,786

 

Research and development

 

75,834

 

495,440

 

2,130,513

 

Sales and marketing

 

150,420

 

525,542

 

2,051,481

 

General and administrative

 

808,054

 

1,403,224

 

5,401,445

 

 

 

 

 

 

 

 

 

Total share-based compensation expense

 

1,124,310

 

2,879,321

 

11,375,225